Adherence and outcomes: a systematic review of palivizumab utilization

Sophie K Wong1, Abby Li1, Krista L Lanctôt1

  • 1a Medical Outcomes and Research in Economics (MORE®) Research Group, Sunnybrook Health Sciences Centre, University of Toronto , Toronto , ON , Canada.

Insights

Consistent adherence to monthly palivizumab dosing is crucial for respiratory syncytial virus (RSV) prophylaxis in young children. This review highlights the need for standardized definitions of adherence to improve evidence on palivizumab effectiveness.

Area of Science:

  • Pediatric Infectious Diseases
  • Immunology
  • Pharmacology

Background:

  • Respiratory syncytial virus (RSV) is a major cause of lower respiratory tract infections in children under two years old.
  • Palivizumab, a monoclonal antibody, is used for RSV prophylaxis, requiring strict monthly dosing for efficacy.
  • Inconsistent adherence can reduce palivizumab's effectiveness and increase the risk of RSV infection and hospitalization.

Purpose of the Study:

  • To review the variability in defining and reporting adherence to palivizumab prophylaxis across studies.
  • To assess the relationship between adherence to monthly dosing protocols and reported outcomes in published trials.

Main Methods:

  • Literature review of studies on palivizumab efficacy and safety.
  • Analysis of adherence definitions and reporting in randomized controlled trials.
  • Assessment of outcome data in relation to adherence to monthly dosing schedules.

Main Results:

  • Significant variability exists in the definition and reporting of palivizumab adherence.
  • A clear relationship between adherence and outcomes needs further investigation due to inconsistent reporting.
  • Lack of standardized adherence metrics complicates the interpretation of palivizumab effectiveness.

Conclusions:

  • Standardized, detailed reporting of palivizumab adherence is essential for robust evidence.
  • Consistent definitions will aid in understanding effectiveness variations and informing guidelines.
  • Improved adherence data can impact cost-effectiveness analyses and clinical recommendations.
Abstract

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
1.8K
Bioequivalence studies: Biowaivers01:13

Bioequivalence studies: Biowaivers

Body:In certain scenarios, in vitro dissolution tests can replace in vivo bioequivalence studies. This is particularly true when a drug product, though available in varying strengths, maintains proportional similarity in its active and inactive ingredients. In such cases, the need for in vivo bioequivalence studies for lower strength variants may be waived, provided dissolution tests and in vivo studies on the highest strength yield satisfactory results.Bioequivalence can be indicated through...
292
Asthma-IV: Nursing Management01:30

Asthma-IV: Nursing Management

The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
3.9K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.2K
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
3.6K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.2K